Comprehensible treatment decisions in Oncology and Radiology
mint Lesion™ supports radiologists and oncologists in assessing the effectiveness of a cancer therapy. On basis of medical image interpretation, it provides immediate feedback about individual patient cases or clinical trial patient cohorts in terms of whether and how patients are responding to a particular treatment.
mint Lesion™ is an approved medical product in the European Union (CE-labeled), the United States (FDA-approved, labeled OncoTrac™), and further countries.
Fields of Application – What can mint Lesion™ be used for?
- mint Lesion™ as Tumor Response Evaluation Solution: Streamline your daily readings and benefit from instant access to in-depth knowledge about any lesion from various imaging modalities. Read more.
- mint Lesion™ as a Clinical Trial Imaging Management System (CTIMS) in clinical pharmaceutical research: Optimize efficiency and quality of clinical trials and benefit from a 100 % compliance to your particular clinical trial protocol. Read more.
- mint Lesion™ in Quantitative Imaging Research: Gain substantial contributions to research by linking your quantitative reading results and benefit from our unique flexibility in modeling individual criteria and procedures with mint Lesion™. Read more.
New working concept improves consistency, quality, and communication of your results
The working concept of mint Lesion™ has been developed from ground up and adapted to suit the needs of oncological radiology and to meet the increasingly complex requirements of cancer therapy monitoring. While improving consistency, quality, and safety, mint Lesion™ aims at leveraging your workload in daily practice, clinical trials, and research. Let mint Lesion™ improve your oncological reading process and bring your daily work one step further towards evidence based medicine.
Background
The development of mint Lesion™ is motivated by the Quantitative Imaging paradigm aiming to systematically optimize the effectiveness of patient treatment. By extraction of quantifiable features from medical images during treatment, mint Lesion™ is designed to meet the increasing demand for making the objective analysis of quantifiable, image-based response parameters an integral part of radiological and oncological practice. Several international initiatives and organizations are committed to advancing radiology from a largely qualitative to an increasingly quantitative science. Among these are the Quantitative Imaging Biomarker Alliance (QIBA) of the RSNA (Radiological Society of North America), and the Quantitative Imaging Network of the NCI (National Cancer Institute, USA). mint Lesion™ contributes to the standardization efforts in Quantitative Imaging as it maps quantitative criteria and working concepts to an optimized software solution for radiological reviewing.
Are you interested in a consultation or do you need more information?
Please feel free to contact us, we are happy to provide further advice.
